ArticleDementia and neurocognitive disorders2026
Baseline Clinical and Neuropsychological Characteristics of Amyloid PET-Confirmed Alzheimer's Disease Treated With Lecanemab: Early Experience at a Tertiary Hospital in Korea.
Hyeongjin Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.